Literature DB >> 33216290

Carcinosarcoma of the ovary: MR and clinical findings compared with high-grade serous carcinoma.

Tsukasa Saida1, Kensaku Mori2, Yumiko Oishi Tanaka3, Masafumi Sakai2, Taishi Amano2, Shunsuke Kikuchi2, Souta Masuoka2, Miki Yoshida2, Tomohiko Masumoto2, Toyomi Satoh4, Manabu Minami2.   

Abstract

PURPOSE: To clarify imaging and clinical characteristics of ovarian carcinosarcoma (CS) compared with high-grade serous carcinoma (HGSC).
METHODS: We retrospectively reviewed MR imagings of 12 patients with CS and 30 patients with HGSC and evaluated tumor size, shape, appearance, nature of cystic and solid components, hemorrhage, and necrosis. Age, premenopausal or postmenopausal, histologic subtype, presence of endometriosis, tumor markers, and stage were also evaluated. These parameters were compared using the Mann-Whitney U test and the chi-square test/Fisher's exact test.
RESULTS: The mean size of CSs was 13.6 cm, and significantly larger than that of HGSCs (mean 9.0 cm, p = 0.022). The stained-glass appearance (67% vs. 23%, p = 0.013), hemorrhage (100% vs. 50%, p = 0.003), necrosis (75.0% vs. 13%, p = 0.000), and endometriosis (33% vs. 7%, p = 0.012) were significantly more common in CSs. The postmenopausal ratio of CSs was 100% and significantly higher than that of HGSCs (70.0%, p = 0.041). Among the tumor makers, only CA-125 was significantly lower in CSs than in HGSCs (mean 715.1 U/ml vs. 1677.1 U/ml, p = 0.009). The stage distribution was similar and was not significantly different.
CONCLUSION: CSs formed larger masses, and the stained-glass appearance, hemorrhage, and necrosis were more frequently observed in CSs.

Entities:  

Keywords:  Cancer; Carcinoma; Magnetic resonance imaging; Malignant mixed epithelial and mesenchymal tumor; Ovarian sarcoma

Year:  2020        PMID: 33216290     DOI: 10.1007/s11604-020-01072-7

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  24 in total

1.  Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach.

Authors:  Yumiko O Tanaka; Satoshi Okada; Toyomi Satoh; Koji Matsumoto; Tsukasa Saida; Akinori Oki; Hiroyuki Yoshikawa; Manabu Minami
Journal:  Eur J Radiol       Date:  2010-06-23       Impact factor: 3.528

2.  Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components.

Authors:  Wenhua Li; Caiting Chu; Yanfen Cui; Ping Zhang; Minjie Zhu
Journal:  Abdom Imaging       Date:  2012-10

Review 3.  Ovarian carcinosarcoma: Current developments and future perspectives.

Authors:  Stergios Boussios; Afroditi Karathanasi; Nikolaos Zakynthinakis-Kyriakou; Alexandros K Tsiouris; Aikaterini A Chatziantoniou; Foivos S Kanellos; Konstantina Tatsi
Journal:  Crit Rev Oncol Hematol       Date:  2018-12-24       Impact factor: 6.312

4.  Ovarian cancer statistics, 2018.

Authors:  Lindsey A Torre; Britton Trabert; Carol E DeSantis; Kimberly D Miller; Goli Samimi; Carolyn D Runowicz; Mia M Gaudet; Ahmedin Jemal; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2018-05-29       Impact factor: 508.702

Review 5.  Carcinosarcoma of the ovary: a review of the literature.

Authors:  Marcela G del Carmen; Michael Birrer; John O Schorge
Journal:  Gynecol Oncol       Date:  2011-12-08       Impact factor: 5.482

6.  Carcinosarcoma of the ovary: 19 years of prospective data from a single center.

Authors:  Ewan Brown; Moira Stewart; Tzyvia Rye; Awatif Al-Nafussi; Alistair R W Williams; Michael Bradburn; John Smyth; Hani Gabra
Journal:  Cancer       Date:  2004-05-15       Impact factor: 6.860

7.  Polycystic ovary syndrome: dynamic contrast-enhanced ovary MR imaging.

Authors:  C Zuhal Erdem; Ulku Bayar; L Oktay Erdem; Aykut Barut; Sadi Gundogdu; Erdal Kaya
Journal:  Eur J Radiol       Date:  2004-07       Impact factor: 3.528

8.  Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.

Authors:  Julie Kunkel; Yan Peng; Yu Tao; Hannah Krigman; Dengfeng Cao
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

9.  Carcinosarcoma of the ovary: a single institution experience and review of the literature.

Authors:  M J Kanis; V Kolev; J Getrajdman; K Zakashansky; C Cohen; J Rahaman
Journal:  Eur J Gynaecol Oncol       Date:  2016       Impact factor: 0.196

10.  Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.

Authors:  Yumiko Oishi Tanaka; Satoshi Okada; Toyomi Satoh; Koji Matsumoto; Akinori Oki; Tsukasa Saida; Hiroyuki Yoshikawa; Manabu Minami
Journal:  Cancer Imaging       Date:  2016-02-12       Impact factor: 3.909

View more
  1 in total

1.  Management of a rare ovarian carcinosarcoma: A case report and literature review.

Authors:  Jun Fu
Journal:  Exp Ther Med       Date:  2022-07-19       Impact factor: 2.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.